Anxiety Disorder and Depression Treatment Market Growth 2022-2028: Increased Awareness About Mental Health Disorder and Improving Treatment Methods

The global Anxiety Disorder and Depression Treatment Market is forecasted to grow at a rate of 2.4% from USD 16.17 Billion in 2020 to USD 19.53 Billion in 2028. The market is mainly driven by the increasing prevalence of mental health issues and disorders like anxiety disorder and depression. It is one of the significant contributing factors boosting the global anxiety disorder and depression treatment market.

Apart from that, the rise in graying population who are susceptible to mental health issues like Alzheimer's, trauma, is also acting as a driving factor for the global Anxiety Disorder and Depression Treatment Market. The demand for anxiety disorder and depression treatment products has significantly increased because of the minimal side effects associated with different drug classes like antidepressants.

Access Free sample PDF Copy of the Report @

However, a rise in the rate of drug withdrawals, an increasing number of a generic drug, the occurrence of mental health issues that are drug-resistant and ineffective pipeline are some of the factors, which may have had an adverse impact on the growth of the market. In spite of these restraints, the fact that individuals are becoming more aware of mental health issues and associated adverse impact on leading a normal life result in having a positive impact on the market.

Anxiety disorders and depression, are among the most prevalent mental health conditions. Though they are less visible than schizophrenia and bipolar disorder, they can be just as disabling. Anxiety disorders affect up to 13.3% of people in the United States, making it the most common group of mental diseases. The Epidemiological Catchments Area study, which took place around 26 years ago, was the first to disclose the scope of their occurrence. Due to their extensive occurrence, these illnesses have received increasing attention in the recent years and are being considered just as important as other syndromes such as mood and psychotic disorders. The primary care physician is often the primary assessor and treatment provider. With improvement in primary healthcare infrastructure around the world, market for anxiety disorder and depression treatment is also expected to grow.

Anxiety disorders can be blamed for lower productivity, higher morbidity and mortality rates, and an increase in alcohol and drug usage in a broad segment of the population. Therefore, to treat such problems, increased attention is being paid to anxiety disorder and depression treatment. The prevalence of favourable reimbursement policies for drugs and therapies in developed economies, is expected to fuel growth during the forecast period.

However, in most cases anxiety disorder and depression treatment can be considerably expensive. Patients with no access to health insurance or good primary care facilities cannot afford such treatments because of their high cost. This can be a restraining factor for market growth in coming years.

Companies considered and profiled in this market study

Pfizer, Johnson & Johnson, Inc., Lundbeck A/S, Inc., GlaxoSmithKline plc., Sanofi- Aventis, Merck & Company, AstraZeneca PLC., Eli Lilly, Forest Laboratories, and Company, Bristol-Myers Squibb Company.

Get In detailed Research Study @ 

Further key findings from the report suggest

  • The rising rate of depression and anxiety disorder as well as the increasing awareness to treat such disorders will drive market growth.
  • In the drug class segment, antidepressants accounted for the highest market share in 2020. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) accounted for 28% of the market revenue share.
  • As a result of higher incidents of suicide, there has been a rise in demand for therapies. In the year 2020, Cognitive Behavior Therapy [CBT] accounted for the largest market share among other therapies segment.
  • In 2020, North America accounted fort the largest revenue share in the anxiety disorder and depression treatment market. Because of increased incidence rate of anxiety disorders and depression in the region, and favourable government policies, North America is expected to continue accounting for a higher revenue share during the forecast period.
  • In terms of market share, the Asia Pacific region also has a considerable share in the worldwide anxiety disorder and depression treatment market. Major reasons for market growth in the APAC region is increasing disposable income and improvement of healthcare sector.

For the purpose of this report, Reports and Data has segmented the global anxiety disorder and depression treatment market based on drug class, therapies, devices, application, end-users, and region:

Download Summary @

Drug Class Outlook (Revenue, USD Billion; 2020 – 2028)

  • Selective Serotonin Reuptake Inhibitors (SSRIs)
  • Antidepressant Drugs
  • Tricyclic Antidepressants (TCAs)
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
  • Monoamine Oxidase Inhibitors (MAOIs)
  • Benzodiazepines
  • Atypical Antipsychotics
  • Anticonvulsants
  • Beta-Blockers
  • Others

Therapies Outlook (Revenue, USD Billion; 2020 – 2028)

  • Electroconvulsive Therapy (ECT)
  • Cognitive Behavior Therapy (CBT)
  • Psychotherapy
  • Deep Brain Stimulation
  • Transcranial Magnetic Stimulation (TMS)
  • Cranial electrotherapy stimulation (CES)

Devices Outlook (Revenue, USD Billion; 2020 – 2028)

  • Cranial electrotherapy stimulator
  • Fisher-Wallace stimulator market

Application Outlook (Revenue, USD Billion; 2020 – 2028)

  • Phobia
  • Major Depressive Disorder
  • Obsessive Compulsive Disorder (OCD)
  • Post-traumatic stress disorder
  • Others

End-users Outlook (Revenue, USD Billion; 2020 – 2028)

  • Hospitals
  • Mental healthcare centers
  • NGOs
  • Asylums

Regional Outlook (Revenue, USD Billion; 2020 – 2028)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

Ask for Customize Research Report @

This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.

Explore Latest Trending Research Reports by Reports and Data's:

Global Audiology Devices Market By Type (Cochlear Implants, Diagnostic Devices, Bone-Anchored Hearing Aids, Technological Hearing Aids, Hearing Aids), By Disease Type (Meniere’s Disease, Otitis Media, Otosclerosis, Tinnitus,Acoustic Tumors, Acoustic Trauma), By End-Use (Hospitals, Audiology Clinics, Rehabilitation Centers, Ambulatory Surgical Centers (ASCs), Others), and By Region Forecast to 2030

Diabetes Devices Market By Type (Blood Glucose Monitoring Systems, Lancets, Test Strips or Test Papers, Insulin Delivery Devices, Diabetes Management Mobile Applications), By Distribution Channels, By End-use, and By Region Forecast to 2028

Contract Research Outsourcing (CRO) Market Size, Share, Trends, By Product Type, By Therapeutic Area, By End-Use, and By Region Forecast to 2028

Parenteral Nutrition Market Size, Share & Analysis, By Nutrient Type (Carbohydrates, Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins And Minerals) By Consumer Type (Children And New-Born, Adults) By End-Use (Clinic, Hospital, And Others), And By Region, Global Forecast To 2028

Immunomodulators Market Analysis, By Product (Immunosuppressants, Immunostimulants, Antibodies), By Application (Oncology, Respiratory, HIV, Others), Forecast To 2027


About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web:
Direct Line: +1-212-710-1370
LinkedIn | Twitter | Blogs

Back to news